Drew Burch, MBA

Drew Burch, MBA, has over 30 years of experience in strategic, operational, commercial, and financial divisions in the life sciences industry. Prior to joining Maravai LifeSciences, he was the president of Softgels at Thermo Fisher Scientific, where he led the division’s CDMO services in the US and Europe. Burch also held multiple leadership positions across other Thermo Fisher Scientific’s business segments, including being the president of Instrument and Enterprise Services and Drug Product Division, Europe, and the vice president of Strategy and Business Development, Life Sciences Solutions. Previously, Burch worked as an advisor to healthcare companies on M&A during his tenures at Barclays Capital, Lehman Brothers, and Merrill Lynch & Co. Burch holds an MBA from Stanford University Graduate School of Business and a BA in economics and political science from Yale University.